The Enteric Nervous System Contains 100 Million Neurons and Produces 90–95% of the Body's Serotonin in the Gut Wall — the Gut Is Communicating With the Brain Continuously Via the Vagus Nerve, Immune Signaling, Microbial Metabolites, and Enteroendocrine Hormones, and the Emerging Science of Psychobiotics Suggests That Specific Bacteria Strains Can Influence Anxiety, Mood, and Stress Responses Through These Pathways
Updated: June 2026gut brain axis · gut brain connection · gut brain · gut and brain · gut brain communication · gut brain pathway · gut brain health · gut brain link · gut feeling brain · microbiome brain · gut microbiome brain · gut bacteria and brain · gut microbiome mood · gut microbiome mental health · gut microbiome anxiety · gut microbiome depression · vagus nerve · vagus nerve gut · vagus nerve gut brain · vagus nerve stimulation · vagal nerve gut · vagal tone · vagus nerve mental health · vagus nerve anxiety · vagus nerve depression · gut vagus nerve · gut-vagus-brain · vagal afferents · cranial nerve X · cholinergic vagus · vagus nerve serotonin · enteric nervous system · ENS · second brain · ENS neurons · enteric neurons · 100 million neurons gut · gut neurons · myenteric plexus · submucosal plexus · Auerbach plexus · Meissner plexus · enteric nervous system function · gut nervous system · how many neurons in gut · gut serotonin · serotonin gut · 95 percent serotonin gut · serotonin made in gut · gut serotonin production · enterochromaffin cells · gut serotonin anxiety · gut serotonin mood · gut serotonin depression · serotonin ENS · gut 5-HT · 5-hydroxytryptamine gut · gut serotonin SSRI · does gut serotonin affect brain · can gut serotonin cross blood brain barrier · tryptophan serotonin gut · tryptophan gut brain · gut tryptophan · tryptophan mood · gut tryptophan anxiety · dietary tryptophan gut · psychobiotics · what are psychobiotics · psychobiotic definition · psychobiotics mental health · psychobiotics anxiety · psychobiotics depression · psychobiotics stress · Dinan Cryan psychobiotics · Dinan Cryan 2013 · psychobiotics 2013 · Lactobacillus rhamnosus JB-1 · JB-1 anxiety · JB-1 mouse study · Bravo 2011 JB-1 · Lactobacillus anxiety · probiotic and anxiety · probiotic and depression · gut bacteria mood · probiotic mental health · probiotic mood · Lactobacillus reuteri · Bifidobacterium longum · gut bacteria serotonin · GABA gut bacteria · probiotic GABA · gut microbiome GABA · gut-brain axis HPA · gut stress axis · gut and cortisol · gut bacteria cortisol · gut and HPA axis · gut inflammation brain · neuroinflammation gut · gut bacteria and brain inflammation · gut LPS brain · lipopolysaccharide brain · leaky gut brain · intestinal permeability brain · gut permeability depression · gut barrier mental health · gut-brain SCFAs · butyrate brain · short chain fatty acids brain · butyrate blood brain barrier · microbial metabolites brain · tryptamine gut · indole gut brain · kynurenine pathway gut · gut kynurenine depression · IDO1 inflammation kynurenine · gut-brain clinical · gut-brain clinical evidence · gut brain IBS · IBS anxiety · IBS depression · gut brain IBD · Crohn's depression · UC depression · gut brain Parkinson · gut Parkinson · gut microbiome Parkinson · alpha synuclein gut · gut brain autism · autism gut microbiome · ADHD gut microbiome
The gut-brain axis — the bidirectional communication network linking the gastrointestinal tract with the central nervous system — is one of the most actively researched frontiers in medicine, and its complexity has repeatedly surprised investigators who assumed the brain was the dominant partner. The gut, it turns out, sends far more signals to the brain than the brain sends to the gut: approximately 80–90% of vagal fibers are afferent (gut-to-brain), not efferent (brain-to-gut). The gut is continuously reporting to the brain — nutrient composition, microbial activity, inflammatory state, osmolarity, distension — and the brain's emotional, cognitive, and behavioral outputs are partly downstream of these gut reports.
This architecture explains phenomena that medicine struggled to classify for decades: why psychological stress causes gastrointestinal symptoms (IBS, functional dyspepsia); why gut disorders (IBD, IBS) have psychiatric comorbidity rates of 30–50%; why vagus nerve stimulation (implanted device, used for epilepsy) has antidepressant effects; why early-life gut microbiome perturbation (antibiotics in infancy) is associated with increased anxiety and depression in adulthood; and why the most effective treatments for IBS include antidepressants (which act on enteric serotonin signaling as much as on brain serotonin). The gut-brain axis is not a metaphor for "gut feelings" — it is a defined anatomical and biochemical communication system with multiple parallel channels.
100M Neurons
the enteric nervous system — the ENS (enteric nervous system) is embedded in the gut wall: two interconnected ganglionated plexuses extend from the esophagus to the rectum; MYENTERIC PLEXUS (Auerbach's plexus): between the longitudinal and circular muscle layers; controls peristalsis (coordinated muscular contraction waves); SUBMUCOSAL PLEXUS (Meissner's plexus): in the submucosa layer; controls secretion, blood flow, and epithelial function; SCALE: approximately 100 million neurons total — more than the spinal cord (which contains ~70 million) and far more than any peripheral nerve; the ENS uses every class of neurotransmitter found in the brain: acetylcholine, dopamine, serotonin (5-HT), GABA, glutamate, substance P, VIP, neuropeptide Y, and more; the ENS can regulate gut motility, secretion, and blood flow INDEPENDENTLY of the brain — it is not merely a relay station for CNS commands; germ-free mice (raised without any gut microbiome) have a less mature ENS — fewer neurons, simpler circuit organization — demonstrating that the microbiome itself shapes the developing enteric nervous system; CLINICAL RELEVANCE: "the second brain" terminology (coined by Michael Gershon, Columbia University, in "The Second Brain," 1998) describes this autonomy; but the ENS is deeply integrated with the vagus and with systemic endocrine/immune signals — autonomy does not mean isolation; IBS (irritable bowel syndrome) involves ENS hypersensitivity: reduced pain threshold in response to normal gut distension — a form of peripheral sensitization that resembles chronic pain sensitization in the CNS; the ENS changes in Parkinson's disease: Lewy bodies (α-synuclein aggregates) are found in the ENS before they appear in the brain — the gut may be the origin site of Parkinson's pathology in some patients (Braak staging hypothesis)
90–95% Serotonin
serotonin is a gut hormone — the most counterintuitive fact in gut-brain biology: approximately 90–95% of the body's total serotonin (5-hydroxytryptamine, 5-HT) is produced in the gastrointestinal tract — specifically by enterochromaffin (EC) cells in the gut epithelium; the brain's serotonin (5–10% of total) is produced by raphe nuclei neurons and is SEPARATED from gut serotonin by the blood-brain barrier — gut 5-HT cannot cross into the brain in significant amounts; SO WHY DOES GUT SEROTONIN MATTER FOR MOOD? the gut's 5-HT acts on INTRINSIC serotonin receptors in the ENS and on VAGAL AFFERENT neurons that carry signals up to the brainstem; gut 5-HT also influences immune cell function (mast cells, macrophages) and epithelial barrier function; the INDIRECT pathway: gut 5-HT → activates 5-HT3 and 5-HT4 receptors on vagal afferents → vagal sensory signal → NTS (nucleus tractus solitarius) in brainstem → distributed to limbic system, hypothalamus, and prefrontal cortex → influences mood, anxiety, and stress responses; MICROBIOME CONTROL OF GUT 5-HT: Yano et al. (2015, Cell): gut microbiota regulate the biosynthesis of serotonin from enterochromaffin cells; germ-free mice had ~60% less colonic 5-HT than conventionally colonized mice; spore-forming Clostridia (SFB and other species) were the primary inducers of EC cell 5-HT production; colonization of germ-free mice with spore-formers restored 5-HT to normal levels and normalized gut motility (serotonin drives intestinal peristalsis — SSRIs cause GI side effects by flooding gut 5-HT receptors); the microbiome-5-HT-vagus-brain chain is one of the most mechanistically compelling gut-brain pathways
Psychobiotics
Dinan and Cryan — the term "psychobiotic" was coined by John Cryan (University College Cork) and Ted Dinan (also UCC) in a 2013 paper in Biological Psychiatry: "Psychobiotics: a novel class of psychotropic"; defined as: live bacteria that, when ingested in adequate amounts, produce a health benefit in patients suffering from psychiatric illness; the PIVOTAL ANIMAL STUDY — Bravo JA et al. (2011, PNAS): Lactobacillus rhamnosus JB-1 (orally fed to mice) vs vehicle controls; RESULTS: JB-1-treated mice showed significantly reduced anxiety behavior in elevated plus maze and open field tests; significantly reduced depressive behavior in forced swim test; significantly reduced stress-induced corticosterone (CORT — mouse equivalent of cortisol); MECHANISM (in the same study): vagotomy (severing the vagus nerve) abolished all behavioral effects; proving the vagal pathway is REQUIRED for this psychobiotic effect — not systemic absorption of bacteria; GABA receptor changes: JB-1 altered GABA-A and GABA-B receptor subunit expression in cortex, hippocampus, and amygdala; HUMAN TRANSLATION: direct human equivalence to the JB-1 result has been mixed; a small human pilot study (Rao et al. 2009): L. helveticus R0052 + B. longum R0175 in healthy volunteers: reduced urinary cortisol, reduced anxiety and depression scores (Hopkins Symptom Checklist); Jacka et al. (SMILES trial, 2017, BMC Medicine): dietary intervention promoting Mediterranean diet in depressed adults — intervention group had significant depression score reduction vs befriending therapy control; CURRENT EVIDENCE SUMMARY: the gut-brain axis is real and mechanistically established; specific psychobiotics show clear effects in animal models; human RCT evidence is promising but inconsistent across strains and populations; no psychobiotic is FDA-approved as a psychiatric treatment; this is an active research frontier, not an established therapy
4 Pathways
how gut talks to brain — the microbiome-gut-brain axis operates via four parallel communication channels: (1) VAGAL PATHWAY: the most direct; vagal afferent neurons are in constant contact with gut epithelial cells and enterochromaffin cells; bacteria do not enter the bloodstream to reach the brain — they communicate via signaling molecules (SCFAs, indoles, secondary bile acids, peptides) that activate vagal afferents → brainstem → brain; the vagus is the information highway; (2) ENDOCRINE PATHWAY: enteroendocrine cells (1% of gut epithelium — the largest endocrine organ in the body) produce 20+ gut hormones in response to luminal contents and microbial signals; GLP-1, CCK, PYY, ghrelin, serotonin — released into the portal circulation → reach systemic circulation → cross the blood-brain barrier at circumventricular organs or act on brain endothelium; the microbiome modulates these hormone secretions (e.g., SCFAs stimulate GLP-1 release from L-cells); (3) IMMUNE PATHWAY: the gut contains 70-80% of the body's immune cells; the microbiome educates and regulates gut immune activity; dysbiotic microbiome → gut inflammation → elevated circulating LPS (lipopolysaccharide from gram-negative bacterial outer membranes) → LPS crosses a compromised BBB → neuroinflammation → microglia activation → depression and cognitive impairment; elevated serum LPS is found in depression, bipolar disorder, and schizophrenia; (4) METABOLIC PATHWAY: microbial metabolites (short-chain fatty acids: butyrate, propionate, acetate; tryptophan metabolites: indole, kynurenine; secondary bile acids: deoxycholic acid, lithocholic acid) are absorbed into systemic circulation and reach the brain; butyrate crosses the BBB and has direct epigenetic effects on brain gene expression (HDAC inhibition); the kynurenine pathway — IDO1 (indoleamine 2,3-dioxygenase, upregulated by inflammation) shunts tryptophan toward kynurenine (neurotoxic) instead of serotonin — is the proposed mechanism linking gut inflammation to depression
Ready to fix this at the root?
The 30-Day Gut Reset is the full day-by-day protocol — mechanisms, dosed repair steps, a diagnostic chapter, food/swap tables, and a maintenance plan, built from the same research on this page.
Get the Gut Reset → $19
Gut-Brain Axis: Evidence by Clinical Condition
| Condition | Gut-Brain Mechanism | Evidence | Intervention |
|---|
| IBS + anxiety/depression | ENS hypersensitivity; 5-HT dysregulation; bidirectional amplification | Strong (30–50% psychiatric comorbidity in IBS) | Low-FODMAP; gut-directed hypnotherapy; tricyclic antidepressants (act on ENS 5-HT) |
| Depression | Kynurenine pathway (IDO1); gut LPS → neuroinflammation; reduced Lactobacillus/Bifidobacterium | Moderate (case-control studies; SMILES trial diet RCT) | Mediterranean diet; specific psychobiotics (research stage) |
| Anxiety | Reduced GABA via vagal pathway; elevated cortisol from gut dysbiosis | Moderate (animal: strong; human: mixed) | L. rhamnosus-based products; stress + gut-supportive diet |
| Parkinson's disease | α-synuclein aggregation begins in ENS (Braak staging); vagal transport to brain | Strong (pathological); clinical correlation data | Research stage; vagotomy data; microbiome diversity |
| Autism (ASD) | Gut dysbiosis present; altered SCFA and 5-HT; GI symptoms in 40–70% of ASD | Moderate (association); fecal transplant data emerging | Gut-targeted interventions under investigation |
Supporting the Gut-Brain Axis — Evidence-Based Dietary Strategies
Dietary fiber and SCFAs: butyrate produced by Faecalibacterium prausnitzii and Roseburia from dietary fiber crosses the blood-brain barrier and exerts HDAC inhibition in the brain — directly influencing gene expression in neurons and microglia; multiple studies show dietary fiber intake inversely associates with depression and anxiety in large cohort studies; target: 25–35g dietary fiber per day from whole grains, vegetables, legumes, and fruit; resistant starch (raw oats, cooled potatoes, green banana flour) is particularly effective for butyrate production; see GutCode's Butyrate guide for resistant starch RS1-RS4 detail.
Tryptophan-rich foods to support the 5-HT pathway: while gut 5-HT cannot cross the BBB, dietary tryptophan is the precursor for both gut and brain serotonin (brain raphe neurons require dietary tryptophan → 5-HTP → 5-HT); the microbiome competes for tryptophan (converting it to indoles and other metabolites); a healthy microbiome allows more tryptophan through to serotonin synthesis; dietary tryptophan-rich foods: turkey (333mg/100g), pumpkin seeds (576mg/100g), chicken (290mg/100g), eggs (167mg/100g), dairy; consuming carbohydrates with tryptophan-rich foods enhances brain tryptophan uptake (insulin reduces competing amino acids in plasma, increasing tryptophan:LNAA ratio → more brain tryptophan transport).
Fermented foods for microbiome-mood connection: Wastyk et al. (2021, Cell): 10-week high-fermented-food diet vs high-fiber diet in healthy adults; fermented food diet produced: significant increase in microbiome diversity (primary finding); significant reduction in 19 inflammatory proteins (including IL-6, IL-12, IL-17a); the diversity increase from fermented foods exceeded what high fiber alone achieved; for gut-brain axis specifically, increased diversity is associated with better mood and reduced anxiety in epidemiological studies; practical implementation: 1–2 servings daily of kefir, plain yogurt, kimchi, sauerkraut, kombucha, miso, or tempeh; diversity of fermented foods matters more than quantity of any single one.
Multi-Strain Probiotic →
Resistant Starch →
More gut microbiome science
As an Amazon Associate, GutCode earns from qualifying purchases made through links on this page. This does not affect the price you pay.